Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults
Beran, Jiří, Peeters, Mathieu, Dewé, Walthère, Raupachová, Jolana, Hobzová, Lenka, Devaster, Jeanne-Marie
Published in BMC infectious diseases (20.05.2013)
Published in BMC infectious diseases (20.05.2013)
Get full text
Journal Article
A phase III, randomized, open-label study to assess the tolerability and immunogenicity of an H5N1 influenza vaccine administered to healthy adults with a 1-, 2-, 3-, or 6-week interval between first and second doses
Beran, Jiri, MD, PhD, Abdel-Messih, Ibrahim A., MD, MPH, Raupachova, Jolana, MD, Hobzova, Lenka, MD, Fragapane, Elena, MD
Published in Clinical therapeutics (01.12.2010)
Published in Clinical therapeutics (01.12.2010)
Get full text
Journal Article